Saba Capital Management, L.P. sold HQL
September 11, 2025 · Form 4 insider transaction
Saba Capital Management, L.P. sold 15,116 shares of Abrdn Life Sciences Investors at $14.28 per share, a transaction worth $215.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
15,116
Price
$14.28
Total value
$215.9K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 11, 2025
Filing dateSeptember 15, 2025
Shares owned after2,953,507
OwnershipIndirect
10b5-1 planNo
AmendedNo